Bahassi El Mustapha, Karyala Saikumar, Tomlinson Craig R, Sartor Maureen A, Medvedovic Mario, Hennigan Robert F
Department of Cell Biology, Neurobiology and Anatomy, University of Cincinnati College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
Clin Exp Metastasis. 2004;21(4):293-304. doi: 10.1023/b:clin.0000046132.46946.dd.
The AP-1 transcription factor plays a critical role in regulating tumor cell proliferation and has been implicated in controlling a program of gene expression that mediates cell motility and invasion in vitro. We have utilized two dominant negative AP-1 constructs, TAM67 and aFos, each fused to GFP, to investigate the role of AP-1 complexes in an invasive, clinically derived human tumor cell line, HT-1080. As expected, high levels of both GFP-TAM67 and GFP-aFos arrested HT-1080 cells in the G1 phase of the cell cycle. Strikingly, at low levels GFP-aFos, but not GFP-TAM67, caused a change in colony morphology, impairment of directional motility in a monolayer wound healing assay, as well as inhibition of chemotaxis and haptotaxis. Microarray analysis identified a novel set of AP-1 target genes, including the tumor suppressor TSCL-1 and regulators of actin cytoskeletal dynamics, including the gelsolin-like actin capping protein CapG. The demonstration that AP-1 regulates the expression of genes involved in tumor cell motility and cytoskeletal dynamics in a clinically derived human tumor cell line identifies new pathways of control for tumor cell motility.
AP-1转录因子在调节肿瘤细胞增殖中起关键作用,并且在控制介导体外细胞运动和侵袭的基因表达程序中发挥作用。我们利用了两种显性负性AP-1构建体TAM67和aFos,它们都与绿色荧光蛋白(GFP)融合,来研究AP-1复合物在一种侵袭性的、临床来源的人肿瘤细胞系HT-1080中的作用。正如预期的那样,高水平的绿色荧光蛋白-TAM67和绿色荧光蛋白-aFos都使HT-1080细胞停滞在细胞周期的G1期。令人惊讶的是,低水平的绿色荧光蛋白-aFos而非绿色荧光蛋白-TAM67,导致了集落形态的改变、单层伤口愈合试验中定向运动能力的受损,以及趋化性和触觉性的抑制。微阵列分析鉴定出一组新的AP-1靶基因,包括肿瘤抑制因子TSCL-1和肌动蛋白细胞骨架动力学的调节因子,如凝溶胶蛋白样肌动蛋白封端蛋白CapG。AP-1在一种临床来源的人肿瘤细胞系中调节参与肿瘤细胞运动和细胞骨架动力学的基因表达,这一发现确定了肿瘤细胞运动控制的新途径。